Embry Dennis PhD entered the industry of Commercial Medical Research in 1998 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213993, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Dennis Embry by calling (520) 299-6770 during business hours. You can also write to the business’ Single Location at 7131 East 18th St, Tucson, Arizona AZ 85710. You can also visit the company’s website at paxis.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Embry Dennis PhD |
Representative: | Dennis Embry |
Place of Business: | 7131 East 18th St, Tucson, AZ 85710 |
Contact Number: | (520) 299-6770 |
Website: | paxis.org |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 6213993 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1998 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Embry Dennis PhD is a company operating from Pima, Arizona providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1998 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 6213993 as Commercial Medical Research.
With a current employee count of 1 to 4, Embry Dennis PhD has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Dennis Embry at (520) 299-6770 for related queries, or to locate its Single Location using the coordinates 32.210242,-110.839723.
The Single Location can also be found at the street address 7131 East 18th St in Tucson, Arizona 85710 and can be engaged online through the company website at paxis.org, the company Twitter , and Facebook page .